Alere reduces share threshold in latest bid to win Axis-Shield
This article was originally published in Clinica
Executive Summary
Alere is continuing its dogged pursuit of IVD specialist Axis-Shield, amending the terms of its offer so it now needs only 50% or more shares to complete the transaction. The firm had previously set an acceptance threshold of 90%.